Proteomic changes at 8 weeks after infection are associated with chronic liver pathology in experimental schistosomiasis

Journal of Proteomics

Volumn 75, Issue 6, 2012, Pages 1838-1848

  Manivannan, Bhagyashree ^a   Jordan, T William ^a   Secor, W Evan ^b   La Flamme, Anne Camille ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

2D DIGE; Hepatosplenic; Liver fibrosis; MALDI TOF TOF; Proteomics; Schistosomiasis

Indexed keywords

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CBA MOUSE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALS; DISEASE PROGRESSION; HEPATOMEGALY; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED CBA; PROTEOMICS; SCHISTOSOMIASIS MANSONI; SPLENOMEGALY;

MUS; SCHISTOSOMA MANSONI;

EID: 84857657027     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.12.025     Document Type: Article

References (18)

1. Crompton D.W.T. How much human helminthiasis is there in the world?. J Parasitol 1999, 85:397-403.
2. Van der Werf M.J., De Vlas S.J., Brooker S., Looman C.W.N., Nagelkerke N.J.D., Habbema J.D.F., et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003, 86:125-139.
3. Freeman G.L., Montesano M.A., Secor W.E., Colley D.G., Howard M.J., Bosshardt S.C. Immunopathogenesis and immunoregulation in schistosomiasis. Distinct chronic pathologic syndromes in CBA/J mice. Ann N Y Acad Sci 1996, 797:151-165.
4. Harvie M., Jordan T.W., LaFlamme A.C. Differential liver protein expression during schistosomiasis. Infect Immun 2007, 75:736-744.
5. Manivannan B., Rawson P., Jordan T.W., Secor W.E., La Flamme A.C. Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis. Infect Immun 2010, 78:618-628.
6. Henderson G.S., Nix N.A., Montesano M.A., Gold D., Freeman G.L., McCurley T.L., et al. Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol 1993, 142:703-714.
7. Montesano M.A., Colley D.G., Willard M.T., Freeman G.L., Secor W.E. Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease. J Exp Med 2002, 195:1223-1228.
8. Manivannan B., Rawson P., Jordan T.W., Karanja D.M.S., Mwinzi P.N.M., Secor W.E., et al. Identification of cytokeratin-18 as a biomarker of mouse and human hepatosplenic schistosomiasis. Infect Immun 2011, 79:2051-2058.
9. GEHealthcare. DeCyder 2D Software, Version 6.5 User Manual. 28-4010-06 AB ed.: GE Healthcare, 2005.
10. Karp N.A., Lilley K.S. Maximising sensitivity for detecting changes in protein expression: Experimental design using minimal CyDyes. Proteomics 2005, 5:3105-3115.
11. Beddek A.J., Rawson P., Peng L., Snell R., Lehnert K., Ward H.E., et al. Profiling the metabolic proteome of bovine mammary tissue. Proteomics 2008, 8:1502-1515.
12. Wang Y., Holmes E., Nicholson J.K., Cloarec O., Chollet J., Tanner M., et al. Metabonomic investigations in mice infected with Schistosoma mansoni: An approach for biomarker identification. Proc Natl Acad Sci U S A 2004, 101:12676-12681.
13. Balog C.I.A., Meissner A., Goraler S., Bladergroen M.R., Vennervald B.J., Mayboroda O.A., et al. Metabonomic investigation of human Schistosoma mansoni infection. Mol Biosyst 2011, 10.1039/c0mb00262c.
14. Pelley R.P., Ruffier J.J., Warren K.S. Suppressive effect of a chronic helminth infection, Schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun 1976, 13:1176-1183.
15. Stein R.A., McDonnell D.P. Estrogen-related receptor α as a therapeutic target in cancer. Endocr Relat Cancer 2006, 13:S25-S32.
16. Anensen N., Haaland I., D'Santos C., Van Belle W., Gjertsen B.T. Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia. Curr Pharm Biotechnol 2006, 7:199-207.
17. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997, 9:240-246.
18. Gustafson W.C., Weiss W.A. Myc proteins as therapeutic targets. Oncogene 2010, 29:1249-1259.